FDA Clears Abbott Dual-Energy Cardiac Ablation Catheter
The TactiFlex Duo combines pulsed field ablation and radiofrequency energy in a single catheter for treating patients with atrial fibrillation.
The TactiFlex Duo combines pulsed field ablation and radiofrequency energy in a single catheter for treating patients with atrial fibrillation.
The FDA-cleared, AI-guided software is now available on Butterfly Network’s handheld ultrasound devices, aiming to enable more healthcare professionals to perform cardiac exams.
The researchers were recognized for their contributions to the field of technology, including advancements in digital twin technology and medical imaging.
The TactiFlex Duo combines pulsed field ablation and radiofrequency energy in a single catheter for treating patients with atrial fibrillation.
Carilion Clinic has partnered with Philips to adopt its cardiovascular care ecosystem for the new Cardiovascular Institute.
Read MoreInspira Technologies introduced the INSPIRA Cardi-ART, a portable modular device that provides oxygen to the brain during cardiac arrest.
Read MoreRestore Medical’s ContraBand device received FDA Breakthrough Device Designation for treating heart failure with reduced ejection fraction.
Read MoreAliveCor has launched the FDA-cleared KAI 12L AI technology and the Kardia 12L ECG System portable ECG solutions.
Read MoreQT Medical announced that it has received 510(k) clearance from the FDA for PCA 500 use in an acute care setting.
Read MoreThe FDA cleared the CorVista System with CAD Add-On to evaluate the presence of significant coronary artery disease as an aid in diagnosis.
Read MoreGenesis MedTech announced that its J-Valve Transfemoral (TF) System has been granted Breakthrough Device designation by the FDA.